Scientific notes

Organ-on-a-Chip: A New Paradigm for Drug Development

Introduction

Organ-on-a-Chip is a potential, multidisciplinary method for in-vitro modeling of disease, drug screening, and precision medicine that simulates in-vitro physiology and pathology.
Organ-on-a-chip technology may be integrated organically into the drug development pipeline for preclinical screening, testing, and translating novel medicines from early drug discovery to bridging the gap between animal and human subject research.

In the future, it will be unprecedented to promote its biomedical applications through further development of customized organ-on-a-chip and ongoing integration of novel engineering tools (i.e. automation handling, 3D printing, in situ multi-Sensor systems) and biological concepts (e.g. patient-induced pluripotent stem cells and organoids).

How to culture vascularized & immunocompetent 3D models in a standard Multiwell

Abstract

The authors state that “The pharmaceutical industry has been desperately searching for efficient drug discovery methods. Organ-on-a-Chip, a cutting-edge technology that can emulate the physiological environment and functionality of human organs on a chip for disease modeling and drug testing, shows great potential for revolutionizing the drug development pipeline.

However, successful translation of this novel engineering platform into routine pharmacological and medical scenarios remains to be realized. In this review, we discuss how the Organ-on-a-Chip technology can have critical roles in different preclinical stages of drug development and highlight the current challenges in translation and commercialization of this technology for the pharmacological and medical end-users.

Moreover, this review sheds light on the future developmental trends and need for a next-generation Organ-on-a-Chip platform to bridge the gap between animal studies and clinical trials for the pharmaceutical industry.”.

References

Ma C, Peng Y, Li H, Chen W. Organ-on-a-Chip: A New Paradigm for Drug Development. Trends Pharmacol Sci. 2021 Feb;42(2):119-133. doi: 10.1016/j.tips.2020.11.009. Epub 2020 Dec 16. PMID: 33341248; PMCID: PMC7990030.

Related Posts

Yannick Jadot Mentions Cherry Biotech’s Organ-on-Chip Technolog...
Cherry Biotech Organ-on-a-Chip technologies mentioned as an alternative to animal drug testing by Yannick Jadot during his interview by Jean...
Read more
Schematic representation of an adipose-tissue-on-chip module illustrating the principal engineering elements that enhance physiological relevance: (i) perfusable lumen with circulating immune cells permitting real-time trafficking; (ii) endothelial monolayer aligned by shear stress to maintain a selective barrier; (iii) continuous perfusion for nutrient delivery and waste removal; (iv) controlled gas exchange enabling oxygen tuning and hypoxia modelling; (v) intrinsic, perfused microvasculature embedded within the stromal-vascular fraction; and (vi) fluidic coupling to a downstream liver compartment to study multi-organ crosstalk. A legend identifies the main cell types and extracellular matrix components.
Adipose Tissue-on-Chip: Perfused Platforms Driving Next-Gen Metab...
Obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD) remain major global health concerns, yet preclinical models continue...
Read more
Introduction to the human body...
The human body: systems, organs, and main functions The human body is composed of several different subsystems ranging from microscopic scal...
Read more

get in touch

Get the best insights about Cherry Biotech by Email Let’s stay in touch!
As part of our commercial prospecting, we may need to process your personal data. For more information, please consult our Privacy Policy